Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Colgate Palmolive Declares 900% Third Interim Dividend For FY13

Colgate Palmolive (India) Ltd. said its board had declared an interim dividend of 900 percent or Re.9.00 per equity share of Rs.1 each for the fiscal year 2013.

The company fixed April 5 as the Record Date for the purpose of payment of interim dividend and it will be paid on April 19, 2013.

The company reported third-quarter net profit of Rs.111 crore, compared with Rs.116 crore in the third-quarter of last year, reflecting a four percent decline. Total income increased by 14 percent to Rs.796 crore from the Rs.701 crore in the year-ago quarter.

At the BSE, Colgate Palmolive (India) shares are currently trading at Rs.1,291, down 1.40 percent from the previous close.

Click here to receive FREE breaking news email alerts for Colgate-Palmolive (India) Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.